Regentis Biomaterials Ltd. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
Regentis Biomaterials Ltd. (RGNT) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $4.94 million for the 12-month period ending 2025-12-31, per its 20-F/A filed 2026-02-27.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2026-02-27
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month |
|---|---|
| 2025-12-31 | $4.94M 20-F/A · filed 2026-02-27 |
| 2024-12-31 | -$3.48M 20-F/A · filed 2026-02-27 |
| 2023-12-31 | $2.02M 20-F/A · filed 2026-02-27 |